REQUEST A DEMO
Total
USD $0.00
Search more companies

Lek - Pharm A. Opalinska sp. k. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Specialty Food Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Electronic Shopping and Mail-Order Houses | All Other Nondepository Credit Intermediation | Advertising Agencies | Marketing Research and Public Opinion Polling
Full name: Lek - Pharm A. Opalinska sp. k. Profile Updated: June 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Lek - Pharm A. Opalinska sp. k. is an enterprise located in Poland, with the main office in Sokolow Podlaski. It operates in the Department Stores industry. The enterprise was incorporated on January 24, 2017. In its most recent financial highlights, the company reported a net sales revenue drop of 2.52% in 2025. During that time, Lek - Pharm A. Opalinska sp. k.’s total assets grew by 19.84%. The net profit margin of Lek - Pharm A. Opalinska sp. k. increased by 5.11% in 2025.

Headquarters
Ul. Walecznych 2
Sokolow Podlaski; Mazowieckie; Postal Code: 08-300

Contact Details: Purchase the Lek - Pharm A. Opalinska sp. k. report to view the information.

Basic Information
Financial Auditors:
Purchase the Lek - Pharm A. Opalinska sp. k. report to view the information.
Incorporation Date:
January 24, 2017
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Lek - Pharm A. Opalinska sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-2.52%
Total Operating Revenue
6.47%
Operating Profit
62.73%
EBITDA
48.93%
Net Profit/Loss for the Period
65.59%
Total Assets
19.84%
Total Equity
N/A
Operating Profit Margin
5.64%
Net Profit Margin
5.11%
Return on Equity (ROE)
N/A
Quick Ratio
0.21%
Cash Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?